Hematocrit and Hemoglobin Management

Normal Reference Ranges

The American Journal of Kidney Diseases recommends normal hemoglobin values of 14.5-15.5 g/dL for adult males/post-menopausal females and 14.0 g/dL for menstruating females, with corresponding normal hematocrit ranges of 47% and 41%, respectively 1
Normal hemoglobin and hematocrit values vary by age and gender, with the following ranges:

Hemoglobin is the preferred measurement over hematocrit due to its stability when blood samples are stored at room temperature, lower variability across automated analyzers, and lack of effect from hyperglycemia 1

The target hemoglobin range for patients with chronic kidney disease should be 11-12 g/dL, with epoetin therapy indicated when hemoglobin falls below this range 2
Epoetin therapy should be used to maintain a target hemoglobin range of 11-12 g/dL in patients with chronic kidney disease, with dose adjustments as needed 2
Iron status should be evaluated before initiating other treatments, and adequate iron availability should be ensured for hemoglobin synthesis 1
The American Journal of Kidney Diseases recommends avoiding targeting normal hematocrit levels in hemodialysis patients with heart disease due to increased risk of adverse events 3

In patients with chronic kidney disease, survival rates improve when hematocrit exceeds 32-33%, with a 10% reduction in mortality risk at hematocrit levels of 33-36% compared to 30-33% 2
The American Journal of Kidney Diseases recommends regular monitoring of hemoglobin and hematocrit in patients on treatment for anemia, with dose adjustments of 25% typically needed to maintain target hemoglobin levels 4

Hematocrit increases with altitude due to increased erythropoietin production, with an increase of approximately 0.2 g/dL at 1,000m, 0.8 g/dL at 2,000m, 1.9 g/dL at 3,000m, and 3.5 g/dL at 4,000m above sea level 5, 6
Current guidelines do not recommend adjusting normal hematocrit ranges for age in adults, and anemia in older adults should not be considered a normal consequence of aging but rather a sign of potential underlying pathology 5

Hematocrit values below the normal range may indicate anemia, which should be investigated when hematocrit falls below 37% in adult males/post-menopausal females or 33% in menstruating females 7, 8

Hemoglobin is generally preferred over hematocrit for clinical assessment due to its greater stability when blood samples are stored at room temperature and lower variability across automated analyzers 7
When hematocrit is measured, samples should be analyzed promptly or refrigerated, as MCV can increase by 2-4% with prolonged storage 7

In chronic kidney disease management, target hematocrit is 33-36% (corresponding to hemoglobin 11-12 g/dL) 6
Survival rates improve when hematocrit exceeds 32-33% in patients with chronic kidney disease 6
For hemodialysis patients, predialysis hematocrit measurements are standard for monitoring anemia 8